Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) Other Non Operating Income: 2011-2025

Historic Other Non Operating Income for Lifecore Biomedical (LFCR) over the last 15 years, with May 2025 value amounting to -$3,000.

  • Lifecore Biomedical's Other Non Operating Income rose 115.52% to $171,000 in Q2 2025 from the same period last year, while for May 2025 it was -$3,000, marking a year-over-year increase of 99.90%. This contributed to the annual value of -$3,000 for FY2025, which is 99.90% up from last year.
  • Latest data reveals that Lifecore Biomedical reported Other Non Operating Income of -$3,000 as of FY2025, which was up 99.90% from -$3.1 million recorded in FY2024.
  • Lifecore Biomedical's 5-year Other Non Operating Income high stood at $760,000 for FY2022, and its period low was -$23.7 million during FY2023.
  • Moreover, its 3-year median value for Other Non Operating Income was -$3.1 million (2024), whereas its average is -$8.9 million.
  • As far as peak fluctuations go, Lifecore Biomedical's Other Non Operating Income slumped by 5,525.13% in 2021, and later soared by 106.93% in 2022.
  • Lifecore Biomedical's Other Non Operating Income (Yearly) stood at -$11.0 million in 2021, then spiked by 106.93% to $760,000 in 2022, then plummeted by 3,223.82% to -$23.7 million in 2023, then spiked by 87.14% to -$3.1 million in 2024, then skyrocketed by 99.90% to -$3,000 in 2025.